一种强大的聚合物/pyridoxamine酶模仿
1Department of Chemistry, Columbia University, New York, New York 10027, USA.
Journal of the American Chemical Society
|May 2, 2002
概括
研究人员开发了一种使用pyridoxamine和polyethyleneimine的酶模仿剂,以将pyruvic酸转化为dl-alanine. 这种新型催化剂显示了8000倍的加速,证明了它在合成化学中的潜力.
科学领域:
- 生物模拟化学 生物模拟化学
- 催化剂是一种催化剂.
- 聚合物科学 聚合物科学
背景情况:
- 转胺反应在生物系统中至关重要.
- 皮里多克萨明是已知的转胺催化剂,但通常需要优化效率.
- 开发高效的合成酶仿真是催化研究的一个关键目标.
研究的目的:
- 为了创建一个高度活跃的酶模仿转化酸到dl-alanine.
- 研究聚合物结构对催化活性的影响.
- 了解聚合物结合酸基团在催化中的作用.
主要方法:
- 皮里多胺与聚乙烯胺的共价连接.
- 用长链基组对聚乙烯胺的功能化.
- 对模仿酶的催化活性在转化酸为dl-alanine的测试.
主要成果:
- 与简单的pyridoxamine相比,这种仿真酶可以实现高达8000倍的加速.
- 催化加速高度依赖于附加的基链的长度.
- 该聚合物提供了必要的酸和基组,用于催化质子转移.
结论:
- 聚合物支持的皮里多胺衍生物可以作为强大的酶模仿剂.
- 基链长度是优化这些模拟物的催化效率的关键因素.
- 这种方法为设计高效的合成催化剂提供了一个有希望的策略.
相关概念视频
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...


